NASDAQ: CNSP
Cns Pharmaceuticals Inc Stock Ownership - Who owns Cns Pharmaceuticals?

Insider buying vs selling

Have Cns Pharmaceuticals Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CNSP insiders and whales buy or sell their stock.

CNSP Shareholders

What type of owners hold Cns Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Cortice Biosciences Inc10.50%573,368$501.70kInsider
John M. Climaco3.95%215,676$188.72kInsider
Waldemar Priebe2.87%156,807$137.21kInsider
Christopher Downs1.89%103,438$90.51kInsider
Jerzy Gumulka0.79%43,006$37.63kInsider
Carl Anthony Evans0.61%33,458$29.28kInsider
Ubs Group Ag0.44%23,978$20.98kInstitution
Ground Swell Capital LLC0.21%11,341$9.92kInstitution
Jeffry R. Keyes0.20%11,100$9.71kInsider
Tower Research Capital LLC Trc0.09%5,111$4.47kInstitution

1 of 2

CNSP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CNSP0.74%20.81%
DRMA8.13%72.53%
CYCC0.79%99.21%Net Selling
VIVS0.36%99.64%
THAR1.42%98.58%Net BuyingNet Buying

Cns Pharmaceuticals Stock Ownership FAQ

Who owns Cns Pharmaceuticals?

Cns Pharmaceuticals (NASDAQ: CNSP) is owned by 0.74% institutional shareholders, 20.81% Cns Pharmaceuticals insiders, and 78.44% retail investors. Cortice Biosciences Inc is the largest individual Cns Pharmaceuticals shareholder, owning 573,368.00 shares representing 10.50% of the company. Cortice Biosciences Inc's Cns Pharmaceuticals shares are currently valued at $501.70k.

If you're new to stock investing, here's how to buy Cns Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.